首页 > 最新文献

Journal Francais D Ophtalmologie最新文献

英文 中文
Investigation of corneal topographic and ocular surface parameters in ocular rosacea based on skin subtypes 根据皮肤亚型调查酒渣鼻患者的角膜地形图和眼表参数。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-10 DOI: 10.1016/j.jfo.2024.104403
N. Yesilirmak , S. Yuzbasioglu , O. Saritas , A. Aktas , J.-L. Bourges
<div><h3>Objective</h3><div>To compare the corneal topographic parameters and ocular surface parameters of ocular rosacea (OR) patients across skin subtypes of the disease and healthy controls.</div></div><div><h3>Methods</h3><div>This prospective study included 180 eyes of 90 OR patients and 60 eyes of 30 healthy controls. Among the OR patients, 30 had phymatous (60 eyes), 30 had erythematotelangiectatic (60 eyes) and 30 had papulopustular skin types (60 eyes). We measured the mean keratometry (Kmean), maximum keratometry (Kmax), thinnest corneal thickness (TCT), central corneal thickness (CCT) and corneal volume (CV) with a topography device (Sirius, Italy). Additionally, we measured tear-film breakup time (TBUT), Meiboscore and Schirmer's test from all participants. We compared parameters across OR skin groups as well as with controls.</div></div><div><h3>Results</h3><div>Kmean and Kmax were significantly steeper in the OR group compared to controls (<em>p</em> <!--><<!--> <!-->0.05). We found significant correlations between “Kmean-Kmax”, “CV-TCT”, “CV-CCT”, and “TCT-CCT” in both groups, while significant correlations between “age-Kmean”, “age-Kmax”, and “Meiboscore-Kmax” were present only in OR patients. When patients were divided into subgroups according to their skin subtypes, the papulopustular and phymatous subgroups had steeper Kmean and Kmax compared to the erythematotelangiectatic and control groups (<em>P</em> <!--><<!--> <!-->0.05). The papulopustular subgroup had lower CCT, lower TBUT and higher Meiboscore compared to the phymatous, erythematotelangiectatic and control groups but lower TCT compared to controls (<em>P</em> <!--><<!--> <!-->0.05). In addition, there were significant correlations between “Kmax-CV”, “Kmax-TCT”, and “Kmax-meiboscore” only in the papulopustular subgroup (<em>P</em> <!--><<!--> <!-->0.05).</div></div><div><h3>Conclusion</h3><div>It appears that the corneas of OR patients are steeper than those of healthy controls; corneal thinning and abnormalities of ocular surface parameters are more pronounced in papulopustular skin types.</div></div><div><h3>Objectif</h3><div>Comparer les paramètres topographiques cornéens et les paramètres de la surface oculaire des patients atteints de rosacée oculaire (RO) selon les sous-types cutanés de la maladie et des témoins sains.</div></div><div><h3>Méthodes</h3><div>Cette étude prospective a inclus 180 yeux de 90 patients RO et 60 yeux de 30 témoins sains. Parmi les patients RO, 30 avaient une peau phymateuse (60 yeux), 30 une peau érythémato-télangiectasique (60 yeux) et 30 une peau papulo-pustuleuse (60 yeux). Nous avons mesuré la kératométrie moyenne (Kmean), la kératométrie maximale (Kmax), l’épaisseur cornéenne la plus fine (TCT), l’épaisseur cornéenne centrale (CCT) et le volume cornéen (CV) avec un appareil topographique (Sirius, Italie). De plus, nous avons mesuré le temps de rupture des larmes (TBUT), le meiboscore et faire le test de Schirmer de tous l
目的:比较不同皮肤类型的酒渣鼻(OR)患者的角膜地形参数和眼表参数。方法:本前瞻性研究包括90例OR患者180眼和30例健康对照60眼。本组患者中,肿型30眼(60眼),毛细血管扩张型30眼(60眼),丘疹型30眼(60眼)。我们使用地形测量仪(Sirius, Italy)测量了平均角膜密度(Kmean)、最大角膜密度(Kmax)、最薄角膜厚度(TCT)、角膜中央厚度(CCT)和角膜体积(CV)。此外,我们测量了所有参与者的泪膜破裂时间(TBUT)、Meiboscore和Schirmer's测试。我们比较了不同皮肤组和对照组的参数。结果:与对照组相比,OR组的Kmean和Kmax明显变陡(p)。结论:OR组患者的角膜似乎比健康对照组变陡;在丘疹性皮肤类型中,角膜变薄和眼表参数异常更为明显。
{"title":"Investigation of corneal topographic and ocular surface parameters in ocular rosacea based on skin subtypes","authors":"N. Yesilirmak ,&nbsp;S. Yuzbasioglu ,&nbsp;O. Saritas ,&nbsp;A. Aktas ,&nbsp;J.-L. Bourges","doi":"10.1016/j.jfo.2024.104403","DOIUrl":"10.1016/j.jfo.2024.104403","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To compare the corneal topographic parameters and ocular surface parameters of ocular rosacea (OR) patients across skin subtypes of the disease and healthy controls.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This prospective study included 180 eyes of 90 OR patients and 60 eyes of 30 healthy controls. Among the OR patients, 30 had phymatous (60 eyes), 30 had erythematotelangiectatic (60 eyes) and 30 had papulopustular skin types (60 eyes). We measured the mean keratometry (Kmean), maximum keratometry (Kmax), thinnest corneal thickness (TCT), central corneal thickness (CCT) and corneal volume (CV) with a topography device (Sirius, Italy). Additionally, we measured tear-film breakup time (TBUT), Meiboscore and Schirmer's test from all participants. We compared parameters across OR skin groups as well as with controls.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Kmean and Kmax were significantly steeper in the OR group compared to controls (&lt;em&gt;p&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.05). We found significant correlations between “Kmean-Kmax”, “CV-TCT”, “CV-CCT”, and “TCT-CCT” in both groups, while significant correlations between “age-Kmean”, “age-Kmax”, and “Meiboscore-Kmax” were present only in OR patients. When patients were divided into subgroups according to their skin subtypes, the papulopustular and phymatous subgroups had steeper Kmean and Kmax compared to the erythematotelangiectatic and control groups (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.05). The papulopustular subgroup had lower CCT, lower TBUT and higher Meiboscore compared to the phymatous, erythematotelangiectatic and control groups but lower TCT compared to controls (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.05). In addition, there were significant correlations between “Kmax-CV”, “Kmax-TCT”, and “Kmax-meiboscore” only in the papulopustular subgroup (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.05).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;It appears that the corneas of OR patients are steeper than those of healthy controls; corneal thinning and abnormalities of ocular surface parameters are more pronounced in papulopustular skin types.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Comparer les paramètres topographiques cornéens et les paramètres de la surface oculaire des patients atteints de rosacée oculaire (RO) selon les sous-types cutanés de la maladie et des témoins sains.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Cette étude prospective a inclus 180 yeux de 90 patients RO et 60 yeux de 30 témoins sains. Parmi les patients RO, 30 avaient une peau phymateuse (60 yeux), 30 une peau érythémato-télangiectasique (60 yeux) et 30 une peau papulo-pustuleuse (60 yeux). Nous avons mesuré la kératométrie moyenne (Kmean), la kératométrie maximale (Kmax), l’épaisseur cornéenne la plus fine (TCT), l’épaisseur cornéenne centrale (CCT) et le volume cornéen (CV) avec un appareil topographique (Sirius, Italie). De plus, nous avons mesuré le temps de rupture des larmes (TBUT), le meiboscore et faire le test de Schirmer de tous l","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 3","pages":"Article 104403"},"PeriodicalIF":1.2,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subthreshold nanosecond laser therapy for chronic central serous chorioretinopathy: A prospective study 阈下纳秒激光治疗慢性中心性浆液性脉络膜视网膜病变:前瞻性研究。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-10 DOI: 10.1016/j.jfo.2024.104372
D. Fraenkel , H. Kaymak , M. Hartmann , W. Aljundi , C. Munteanu , B. Seitz , A.D. Abdin
<div><h3>Purpose</h3><div>To investigate the morphologic and functional outcomes of nanosecond subthreshold (ST) laser treatment for patients with chronic central serous chorioretinopathy (CSC).</div></div><div><h3>Methods</h3><div>In this prospective study, 44 patients were treated with the ST nanosecond laser with a follow-up period of 12 months. All target variables were measured at 1, 3, 6 and 12 months after the first laser treatment.</div></div><div><h3>Results</h3><div>This study showed a significant improvement in macular sensitivity (MS), a significant reduction in central macular thickness (CMT) as well as a significant reduction in subretinal fluid height (SRF) after 3 months of treatment. The subfoveal choroidal thickness (SFCT) was significantly reduced after 12 months of treatment. However, the best-corrected visual acuity (BCVA) (logMAR) did not change significantly at any time during the study. A high proportion of patients (85%) showed complete resolution of SRF after 12 months, indicating a positive response to treatment in the majority of our patients.</div></div><div><h3>Conclusion</h3><div>This study showed statistically significant functional improvement in MS as well as significant anatomical reduction in CMT, SFCT and SRF height in CSC patients treated with ST nanosecond laser therapy. Patients with higher SRF at baseline required repeated laser treatments to achieve complete resolution of the SRF.</div></div><div><h3>Objectif</h3><div>Étudier les résultats morphologiques et fonctionnels du traitement au <em>subthreshold</em> (ST) <em>nanolaser</em> pour les patients atteints de choriorétinopathie centrale séreuse chronique (CCS).</div></div><div><h3>Méthodes</h3><div>Dans cette étude prospective, 44 patients ont été traités au ST <em>nanolaser</em> avec une période de suivi de 12 mois. Toutes les variables ont été mesurées à 1, 3, 6 et 12 mois après le premier traitement au laser.</div></div><div><h3>Résultats</h3><div>Cette étude a démontré une amélioration significative de la sensibilité maculaire (SM) et une réduction significative de l’épaisseur maculaire centrale (EMC), ainsi que de la hauteur du liquide sous-rétinien (LSR) après 3 mois de traitement. L’épaisseur choroïdienne sous-fovéale (ECSF) n’a été significativement réduite qu’après 12 mois de traitement. Cependant, la meilleure acuité visuelle corrigée (MAVC) (logMAR) n’a pas changé de manière significative durant l’étude. La majorité des patients (85 %) a montré une résolution complète du LSR après 12 mois, ce qui indique une réponse positive au traitement.</div></div><div><h3>Conclusion</h3><div>Cette étude a démontré une amélioration statistiquement significative de la SM ainsi qu’une réduction significative de l’EMT, de l’ECSF et de la hauteur du LSR chez les patients atteints de CCS traités au ST <em>nanolaser</em>. Les patients présentant un LSR plus élevé au départ ont dû subir plusieurs traitements pour obtenir une résolution complète du LSR.</div></div
目的:探讨纳秒阈下(ST)激光治疗慢性中枢性浆液性脉络膜视网膜病变(CSC)的形态学和功能预后。方法:在前瞻性研究中,44例患者接受ST纳秒激光治疗,随访12个月。在第一次激光治疗后1、3、6和12个月测量所有目标变量。结果:本研究显示,治疗3个月后,黄斑敏感性(MS)显著改善,黄斑中央厚度(CMT)显著降低,视网膜下液高度(SRF)显著降低。治疗12个月后,中央凹下脉络膜厚度(SFCT)明显降低。然而,在研究过程中,最佳矫正视力(BCVA) (logMAR)在任何时候都没有明显变化。高比例的患者(85%)在12个月后显示SRF完全消退,这表明我们的大多数患者对治疗有积极反应。结论:本研究显示,在接受ST纳秒激光治疗的CSC患者中,MS的功能改善具有统计学意义,CMT、SFCT和SRF高度在解剖学上也有显著降低。基线时SRF较高的患者需要重复激光治疗以达到SRF的完全消退。
{"title":"Subthreshold nanosecond laser therapy for chronic central serous chorioretinopathy: A prospective study","authors":"D. Fraenkel ,&nbsp;H. Kaymak ,&nbsp;M. Hartmann ,&nbsp;W. Aljundi ,&nbsp;C. Munteanu ,&nbsp;B. Seitz ,&nbsp;A.D. Abdin","doi":"10.1016/j.jfo.2024.104372","DOIUrl":"10.1016/j.jfo.2024.104372","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To investigate the morphologic and functional outcomes of nanosecond subthreshold (ST) laser treatment for patients with chronic central serous chorioretinopathy (CSC).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;In this prospective study, 44 patients were treated with the ST nanosecond laser with a follow-up period of 12 months. All target variables were measured at 1, 3, 6 and 12 months after the first laser treatment.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;This study showed a significant improvement in macular sensitivity (MS), a significant reduction in central macular thickness (CMT) as well as a significant reduction in subretinal fluid height (SRF) after 3 months of treatment. The subfoveal choroidal thickness (SFCT) was significantly reduced after 12 months of treatment. However, the best-corrected visual acuity (BCVA) (logMAR) did not change significantly at any time during the study. A high proportion of patients (85%) showed complete resolution of SRF after 12 months, indicating a positive response to treatment in the majority of our patients.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;This study showed statistically significant functional improvement in MS as well as significant anatomical reduction in CMT, SFCT and SRF height in CSC patients treated with ST nanosecond laser therapy. Patients with higher SRF at baseline required repeated laser treatments to achieve complete resolution of the SRF.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Étudier les résultats morphologiques et fonctionnels du traitement au &lt;em&gt;subthreshold&lt;/em&gt; (ST) &lt;em&gt;nanolaser&lt;/em&gt; pour les patients atteints de choriorétinopathie centrale séreuse chronique (CCS).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Dans cette étude prospective, 44 patients ont été traités au ST &lt;em&gt;nanolaser&lt;/em&gt; avec une période de suivi de 12 mois. Toutes les variables ont été mesurées à 1, 3, 6 et 12 mois après le premier traitement au laser.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;div&gt;Cette étude a démontré une amélioration significative de la sensibilité maculaire (SM) et une réduction significative de l’épaisseur maculaire centrale (EMC), ainsi que de la hauteur du liquide sous-rétinien (LSR) après 3 mois de traitement. L’épaisseur choroïdienne sous-fovéale (ECSF) n’a été significativement réduite qu’après 12 mois de traitement. Cependant, la meilleure acuité visuelle corrigée (MAVC) (logMAR) n’a pas changé de manière significative durant l’étude. La majorité des patients (85 %) a montré une résolution complète du LSR après 12 mois, ce qui indique une réponse positive au traitement.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Cette étude a démontré une amélioration statistiquement significative de la SM ainsi qu’une réduction significative de l’EMT, de l’ECSF et de la hauteur du LSR chez les patients atteints de CCS traités au ST &lt;em&gt;nanolaser&lt;/em&gt;. Les patients présentant un LSR plus élevé au départ ont dû subir plusieurs traitements pour obtenir une résolution complète du LSR.&lt;/div&gt;&lt;/div","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 3","pages":"Article 104372"},"PeriodicalIF":1.2,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and safety of Descemet's membrane endothelial keratoplasty (DMEK) as a surgical treatment for corneal endothelial dysfunction: A multicenter study Descemet的膜内皮角膜移植术(DMEK)作为手术治疗角膜内皮功能障碍的疗效和安全性:一项多中心研究。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-10 DOI: 10.1016/j.jfo.2024.104406
A. Aulanier, N. Todd, N. Stolowy, M. Gonzalvez, T. David
<div><h3>Purpose</h3><div>To analyze the outcomes and frequency of complications after Descemet's membrane endothelial keratoplasty (DMEK) and evaluate the parameters associated with the occurrence of these complications.</div></div><div><h3>Methods</h3><div>A multicenter retrospective study of 143 DMEK procedures performed consecutively by five surgeons between June 2018 and March 2021 was performed. Surgeon-specific surgical and graft characteristics were also assessed. Data on best-corrected visual acuity (BCVA), central pachymetry, and endothelial cell density (ECD) were collected at one, three, six, and 12<!--> <!-->months. Postoperative complications and secondary procedures (rebubbling and regrafting) were also recorded.</div></div><div><h3>Results</h3><div>The mean BCVA at one year was 0.17 logMAR (±0.19). There was a mean hyperopic shift at one year of +0.26 diopters. The mean pachymetry at one year was 526<!--> <!-->μm (±53). The mean ECD at one year was 1164<!--> <!-->cells/mm<sup>2</sup> (±479). Graft detachment occurred in 51% of the procedures and was significantly associated with the performance of an intraoperative iridotomy (OR<!--> <!-->=<!--> <!-->2.8) [95% CI: 1.2–6.6]. Rebubbling occurred in 34% of the procedures, and a new graft was performed in 21% of cases.</div></div><div><h3>Conclusion</h3><div>Performing a peripheral iridotomy during DMEK is a significant risk factor for graft detachment. DMEK significantly improves patients’ vision and restores normal pachymetry.</div></div><div><h3>But</h3><div>Analyser les résultats et la fréquence des complications après une kératoplastie endothéliale de la membrane de Descemet (DMEK) et évaluer les paramètres associés à la survenue de ces complications.</div></div><div><h3>Méthodes</h3><div>Une étude rétrospective multicentrique portant sur 143 procédures de DMEK réalisées consécutivement par cinq chirurgiens entre juin 2018 et mars 2021 a été réalisée. Les caractéristiques chirurgicales propres à chaque opérateur et les caractéristiques des greffons ont été recueillies. La meilleure acuité visuelle corrigée (MAVC), la pachymétrie centrale, la densité cellulaire endothéliale, étaient recueillies à un mois, trois mois, six mois et 12 mois. Les complications postopératoires et les procédures secondaires (<em>rebubbling</em> et regreffe) étaient recueillies.</div></div><div><h3>Résultats</h3><div>La MAVC moyenne à un an était de 0,17 (±0,19) logMAR. Il existait un shift hypermétropique moyen à un an de +0,26 dioptries. La pachymétrie moyenne à 1 an était de 526 (±53) μm. La densité cellulaire endothéliale moyenne à un an était de 1164 (±479) cellules/mm<sup>2</sup>. Le décollement du greffon concernait 51 % des procédures, et était associé significativement à la réalisation d’une iridotomie peropératoire (OR<!--> <!-->=<!--> <!-->2,8) [IC95 % : 1,2–6,6]. Le rebubbling concernait 34 % des procédures et une nouvelle greffe était réalisée dans 21 % des cas.</div></div><div><h3>Conclusion
目的:分析Descemet膜内皮角膜移植术(DMEK)术后并发症的发生情况和发生率,并对并发症发生的相关参数进行评价。方法:对2018年6月至2021年3月期间由5名外科医生连续实施的143例DMEK手术进行多中心回顾性研究。还评估了外科医生特定的手术和移植物特征。在1个月、3个月、6个月和12个月时收集最佳矫正视力(BCVA)、中心厚度测量和内皮细胞密度(ECD)数据。术后并发症和二次手术(再泡和再植骨)也有记录。结果:1年平均BCVA为0.17 logMAR(±0.19)。一年的平均远视位移为+0.26屈光度。1年平均厚测度为526μm(±53)。1年平均ECD为1164cells/mm2(±479)。51%的手术发生了移植物脱离,并且与术中虹膜切开术的效果显著相关(OR=2.8) [95% CI: 1.2-6.6]。在34%的手术中再次冒泡,21%的病例进行了新的移植物。结论:DMEK术中周围虹膜切开术是导致移植物脱离的重要危险因素。DMEK可显著改善患者视力,恢复正常视厚。
{"title":"Outcomes and safety of Descemet's membrane endothelial keratoplasty (DMEK) as a surgical treatment for corneal endothelial dysfunction: A multicenter study","authors":"A. Aulanier,&nbsp;N. Todd,&nbsp;N. Stolowy,&nbsp;M. Gonzalvez,&nbsp;T. David","doi":"10.1016/j.jfo.2024.104406","DOIUrl":"10.1016/j.jfo.2024.104406","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To analyze the outcomes and frequency of complications after Descemet's membrane endothelial keratoplasty (DMEK) and evaluate the parameters associated with the occurrence of these complications.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A multicenter retrospective study of 143 DMEK procedures performed consecutively by five surgeons between June 2018 and March 2021 was performed. Surgeon-specific surgical and graft characteristics were also assessed. Data on best-corrected visual acuity (BCVA), central pachymetry, and endothelial cell density (ECD) were collected at one, three, six, and 12&lt;!--&gt; &lt;!--&gt;months. Postoperative complications and secondary procedures (rebubbling and regrafting) were also recorded.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The mean BCVA at one year was 0.17 logMAR (±0.19). There was a mean hyperopic shift at one year of +0.26 diopters. The mean pachymetry at one year was 526&lt;!--&gt; &lt;!--&gt;μm (±53). The mean ECD at one year was 1164&lt;!--&gt; &lt;!--&gt;cells/mm&lt;sup&gt;2&lt;/sup&gt; (±479). Graft detachment occurred in 51% of the procedures and was significantly associated with the performance of an intraoperative iridotomy (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;2.8) [95% CI: 1.2–6.6]. Rebubbling occurred in 34% of the procedures, and a new graft was performed in 21% of cases.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Performing a peripheral iridotomy during DMEK is a significant risk factor for graft detachment. DMEK significantly improves patients’ vision and restores normal pachymetry.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;But&lt;/h3&gt;&lt;div&gt;Analyser les résultats et la fréquence des complications après une kératoplastie endothéliale de la membrane de Descemet (DMEK) et évaluer les paramètres associés à la survenue de ces complications.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Une étude rétrospective multicentrique portant sur 143 procédures de DMEK réalisées consécutivement par cinq chirurgiens entre juin 2018 et mars 2021 a été réalisée. Les caractéristiques chirurgicales propres à chaque opérateur et les caractéristiques des greffons ont été recueillies. La meilleure acuité visuelle corrigée (MAVC), la pachymétrie centrale, la densité cellulaire endothéliale, étaient recueillies à un mois, trois mois, six mois et 12 mois. Les complications postopératoires et les procédures secondaires (&lt;em&gt;rebubbling&lt;/em&gt; et regreffe) étaient recueillies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;div&gt;La MAVC moyenne à un an était de 0,17 (±0,19) logMAR. Il existait un shift hypermétropique moyen à un an de +0,26 dioptries. La pachymétrie moyenne à 1 an était de 526 (±53) μm. La densité cellulaire endothéliale moyenne à un an était de 1164 (±479) cellules/mm&lt;sup&gt;2&lt;/sup&gt;. Le décollement du greffon concernait 51 % des procédures, et était associé significativement à la réalisation d’une iridotomie peropératoire (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;2,8) [IC95 % : 1,2–6,6]. Le rebubbling concernait 34 % des procédures et une nouvelle greffe était réalisée dans 21 % des cas.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 3","pages":"Article 104406"},"PeriodicalIF":1.2,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crystalline keratopathy associated with fungal superinfection 与真菌超级感染有关的结晶性角膜病。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104304
H. Etxabe Ávila, P. Pérez García, M. Molero-Senosiaín
{"title":"Crystalline keratopathy associated with fungal superinfection","authors":"H. Etxabe Ávila,&nbsp;P. Pérez García,&nbsp;M. Molero-Senosiaín","doi":"10.1016/j.jfo.2024.104304","DOIUrl":"10.1016/j.jfo.2024.104304","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104304"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term clinical and confocal microscopy changes after synthetic endothelial replacement 合成内皮替换后的短期临床和共聚焦显微镜变化。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104302
L. Fernández-Vega-Cueto, C. Lisa, R. Alvarado-Villacorta
{"title":"Short-term clinical and confocal microscopy changes after synthetic endothelial replacement","authors":"L. Fernández-Vega-Cueto,&nbsp;C. Lisa,&nbsp;R. Alvarado-Villacorta","doi":"10.1016/j.jfo.2024.104302","DOIUrl":"10.1016/j.jfo.2024.104302","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104302"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent full-thickness macular hole covered with wrinkled amniotic membrane graft 复发性全厚黄斑孔,用皱褶羊膜移植覆盖。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104358
L. Sejournet , T. Mathis , R. Serra , V. Vermot-Desroches , L. Kodjikian
{"title":"Recurrent full-thickness macular hole covered with wrinkled amniotic membrane graft","authors":"L. Sejournet ,&nbsp;T. Mathis ,&nbsp;R. Serra ,&nbsp;V. Vermot-Desroches ,&nbsp;L. Kodjikian","doi":"10.1016/j.jfo.2024.104358","DOIUrl":"10.1016/j.jfo.2024.104358","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104358"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142693014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the thigh to the eye: Management of necrotizing scleritis using fascia lata graft 从大腿到眼睛使用筋膜移植治疗坏死性巩膜炎。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104308
T. Abdellaoui , S. Sebbata , A. Zaizi , S. Bouabbadi , Y. Mouzari , A. Oubaaz
{"title":"From the thigh to the eye: Management of necrotizing scleritis using fascia lata graft","authors":"T. Abdellaoui ,&nbsp;S. Sebbata ,&nbsp;A. Zaizi ,&nbsp;S. Bouabbadi ,&nbsp;Y. Mouzari ,&nbsp;A. Oubaaz","doi":"10.1016/j.jfo.2024.104308","DOIUrl":"10.1016/j.jfo.2024.104308","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104308"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microphtalmie colobomateuse bilatérale avec kyste orbitaire unilatéral [双侧疣状小眼伴单侧眼眶囊肿]。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104320
J. Jacquemart, L. Hamoudi, A. Mekerke
{"title":"Microphtalmie colobomateuse bilatérale avec kyste orbitaire unilatéral","authors":"J. Jacquemart,&nbsp;L. Hamoudi,&nbsp;A. Mekerke","doi":"10.1016/j.jfo.2024.104320","DOIUrl":"10.1016/j.jfo.2024.104320","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104320"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal imaging, electrophysiology and follow-up of “Dark without Pressure”: Case report 多模态成像、电生理学和 "无压黑暗 "的随访:病例报告。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104114
L. Van Den Eeckhaute, B. Docquier, L. Postelmans
{"title":"Multimodal imaging, electrophysiology and follow-up of “Dark without Pressure”: Case report","authors":"L. Van Den Eeckhaute,&nbsp;B. Docquier,&nbsp;L. Postelmans","doi":"10.1016/j.jfo.2024.104114","DOIUrl":"10.1016/j.jfo.2024.104114","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104114"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Névrite optique associée aux anticorps anti-glycoprotéine de la myéline oligodendrocytaire postinfection au SARS-CoV-2 : suivi de quinze mois [SARS-CoV-2感染后髓鞘少突胶质细胞糖蛋白抗体相关性视神经炎:15个月随访]。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.jfo.2024.104307
A. Zahaf , H. Lajmi , A. Kamoun , S. Sioud , I. Abdelkafi , R. Bourguiba , B. Ben Achour
{"title":"Névrite optique associée aux anticorps anti-glycoprotéine de la myéline oligodendrocytaire postinfection au SARS-CoV-2 : suivi de quinze mois","authors":"A. Zahaf ,&nbsp;H. Lajmi ,&nbsp;A. Kamoun ,&nbsp;S. Sioud ,&nbsp;I. Abdelkafi ,&nbsp;R. Bourguiba ,&nbsp;B. Ben Achour","doi":"10.1016/j.jfo.2024.104307","DOIUrl":"10.1016/j.jfo.2024.104307","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 1","pages":"Article 104307"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal Francais D Ophtalmologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1